Healthcare · Vaccine antigens production
Egypt does not produce its own vaccine antigens — in 2026 the volume was 0 million doses. Despite ranking 72 out of 197 countries, this reflects the absence of industrial synthesis of active substances. The country imports finished vaccines and antigens from India, China, and Europe, then packages them at state-owned VACSERA facilities. Domestic antigen production remains a strategic goal but requires major biotech investment.
Data for 2026 · unit: million doses
Position
#72 / 197
Egypt world ranking
Country position on the scale from last to first place for this indicator.
EG
#72
#197#1
Trend
Change over time
Change in indicator over the available period.
1
1950
0
1990
0
2000
0
2010
0
2020
0
2025
0
2026
Values — million doses
Comparison
Top countries by Vaccine antigens production
Where Egypt stands in the world ranking.
1
CNChina
5 K
2
USUSA
500
3
BRBrazil
400
4
FRFrance
160
5
INIndia
100
5
RURussia
100
7
CACanada
60
8
AUAustralia
50
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Vaccine antigens production in Egypt — how much?
Based on 2026 data — 0 million doses. This is rank #72 out of 197 countries.
What is Egypt's rank by Vaccine antigens production?
Egypt ranks #72 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Egypt?
Over the available period the indicator changed from 1 to 0 million doses.